David Hung's Net Worth
$214 Million
Who is David Hung?
David Hung has an estimated net worth of $214 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., NovoCure Ltd, ESTABLISHMENT LABS HOLDINGS INC., ARYA SCIENCES ACQUISITION CORP., Axovant Sciences Ltd., Opexa Therapeutics, Inc., and MEDIVATION, INC..
SEC CIK
David Hung's CIK is 0001310880
Past Insider Trading and Trends
2021 was David Hung's most active year for acquiring shares with 7 total transactions. David Hung's most active month to acquire stocks was the month of May. 2012 was David Hung's most active year for disposing of shares, totalling 20 transactions. David Hung's most active month to dispose stocks was the month of August. 2021 saw David Hung paying a total of $20,000,000.00 for 60,037,550 shares, this is the most they've acquired in one year. In 2015 David Hung cashed out on 234,140 shares for a total of $26,092,708.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| -0.63% | -368.41K |
—
|
—
| 58.28M |
Mar 2 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
∞
| 58.65M |
$10.00 |
—
| 58.65M |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NovoCure Ltd (NVCR) Snapshot price: $16.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.34% | 4.05K |
—
|
—
| 13.19K |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +36.15% | 2.43K |
—
|
—
| 9.14K |
Jun 8
| |||
Form 4
| +13.80% | 814 |
—
|
—
| 6.71K |
Jun 9
| |||
Form 4
| +75.65% | 2.54K |
—
|
—
| 5.9K |
Jun 10
| |||
Form 4
|
∞
| 3.36K |
—
|
—
| 3.36K |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
| No matching records found | |||||||||
ESTABLISHMENT LABS HOLDINGS INC. (ESTA) Snapshot price: $41.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYA SCIENCES ACQUISITION CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Principal Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
∞
| 539.38K |
$18.54 | $10,000,012.50 | 539.38K |
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||